[Somatostatin in breast cancer].
Identifieur interne : 002470 ( PubMed/Corpus ); précédent : 002469; suivant : 002471[Somatostatin in breast cancer].
Auteurs : Albane Frati ; Martine Antoine ; Anita Rodenas ; Joseph Gligorov ; Roman Rouzier ; Elisabeth ChéreauSource :
- Annales de biologie clinique [ 0003-3898 ]
English descriptors
- KwdEn :
- Antineoplastic Agents, Hormonal (therapeutic use), Breast Neoplasms (diagnosis), Breast Neoplasms (drug therapy), Breast Neoplasms (surgery), Early Detection of Cancer, Female, Humans, Lymph Node Excision (adverse effects), Lymphedema (etiology), Lymphedema (prevention & control), Mastectomy (adverse effects), Somatostatin (analogs & derivatives), Treatment Outcome.
- MESH :
- chemical , analogs & derivatives : Somatostatin.
- chemical , therapeutic use : Antineoplastic Agents, Hormonal.
- adverse effects : Lymph Node Excision, Mastectomy.
- diagnosis : Breast Neoplasms.
- drug therapy : Breast Neoplasms.
- etiology : Lymphedema.
- prevention & control : Lymphedema.
- surgery : Breast Neoplasms.
- Early Detection of Cancer, Female, Humans, Treatment Outcome.
Abstract
In man, somatostatin is a hormone mostly produced by hypothalamus. It plays different parts in hormonal regulation through many specific receptors in human body. It has also two interesting actions such as an anti-secretory activity, mostly on the gastrointestinal system and an antiproliferative action on tumor cells. Many synthetic somatostatin analogues, more stable than the natural one, have been developed and are already used in digestive surgery to treat postoperative digestive fistula. Also, the development of specific polyclonal antibodies allowed the identification of five specific somatostatin receptors and their localization in different cell species. The presence of the five receptors in breast cancer cells has than been demonstrated. The purpose of this literature review is to clarify the potential antitumor effect of somatastatin analogues in breast cancer; its use as a preventive agent on lymphorrhea after breast surgery and its employment in imaging for early breast cancer detection.
DOI: 10.1684/abc.2011.0588
PubMed: 21896402
Links to Exploration step
pubmed:21896402Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Somatostatin in breast cancer].</title><author><name sortKey="Frati, Albane" sort="Frati, Albane" uniqKey="Frati A" first="Albane" last="Frati">Albane Frati</name><affiliation><nlm:affiliation>Service de gynécologie obstétrique, Hôpital Tenon, APHP, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Antoine, Martine" sort="Antoine, Martine" uniqKey="Antoine M" first="Martine" last="Antoine">Martine Antoine</name></author><author><name sortKey="Rodenas, Anita" sort="Rodenas, Anita" uniqKey="Rodenas A" first="Anita" last="Rodenas">Anita Rodenas</name></author><author><name sortKey="Gligorov, Joseph" sort="Gligorov, Joseph" uniqKey="Gligorov J" first="Joseph" last="Gligorov">Joseph Gligorov</name></author><author><name sortKey="Rouzier, Roman" sort="Rouzier, Roman" uniqKey="Rouzier R" first="Roman" last="Rouzier">Roman Rouzier</name></author><author><name sortKey="Chereau, Elisabeth" sort="Chereau, Elisabeth" uniqKey="Chereau E" first="Elisabeth" last="Chéreau">Elisabeth Chéreau</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>2011 Jul-Aug</MedlineDate></PubDate></date><idno type="RBID">pubmed:21896402</idno><idno type="pmid">21896402</idno><idno type="doi">10.1684/abc.2011.0588</idno><idno type="wicri:Area/PubMed/Corpus">002470</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002470</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Somatostatin in breast cancer].</title><author><name sortKey="Frati, Albane" sort="Frati, Albane" uniqKey="Frati A" first="Albane" last="Frati">Albane Frati</name><affiliation><nlm:affiliation>Service de gynécologie obstétrique, Hôpital Tenon, APHP, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Antoine, Martine" sort="Antoine, Martine" uniqKey="Antoine M" first="Martine" last="Antoine">Martine Antoine</name></author><author><name sortKey="Rodenas, Anita" sort="Rodenas, Anita" uniqKey="Rodenas A" first="Anita" last="Rodenas">Anita Rodenas</name></author><author><name sortKey="Gligorov, Joseph" sort="Gligorov, Joseph" uniqKey="Gligorov J" first="Joseph" last="Gligorov">Joseph Gligorov</name></author><author><name sortKey="Rouzier, Roman" sort="Rouzier, Roman" uniqKey="Rouzier R" first="Roman" last="Rouzier">Roman Rouzier</name></author><author><name sortKey="Chereau, Elisabeth" sort="Chereau, Elisabeth" uniqKey="Chereau E" first="Elisabeth" last="Chéreau">Elisabeth Chéreau</name></author></analytic><series><title level="j">Annales de biologie clinique</title><idno type="ISSN">0003-3898</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antineoplastic Agents, Hormonal (therapeutic use)</term><term>Breast Neoplasms (diagnosis)</term><term>Breast Neoplasms (drug therapy)</term><term>Breast Neoplasms (surgery)</term><term>Early Detection of Cancer</term><term>Female</term><term>Humans</term><term>Lymph Node Excision (adverse effects)</term><term>Lymphedema (etiology)</term><term>Lymphedema (prevention & control)</term><term>Mastectomy (adverse effects)</term><term>Somatostatin (analogs & derivatives)</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Somatostatin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Agents, Hormonal</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term><term>Mastectomy</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Early Detection of Cancer</term><term>Female</term><term>Humans</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In man, somatostatin is a hormone mostly produced by hypothalamus. It plays different parts in hormonal regulation through many specific receptors in human body. It has also two interesting actions such as an anti-secretory activity, mostly on the gastrointestinal system and an antiproliferative action on tumor cells. Many synthetic somatostatin analogues, more stable than the natural one, have been developed and are already used in digestive surgery to treat postoperative digestive fistula. Also, the development of specific polyclonal antibodies allowed the identification of five specific somatostatin receptors and their localization in different cell species. The presence of the five receptors in breast cancer cells has than been demonstrated. The purpose of this literature review is to clarify the potential antitumor effect of somatastatin analogues in breast cancer; its use as a preventive agent on lymphorrhea after breast surgery and its employment in imaging for early breast cancer detection.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21896402</PMID><DateCreated><Year>2011</Year><Month>09</Month><Day>07</Day></DateCreated><DateCompleted><Year>2011</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2011</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-3898</ISSN><JournalIssue CitedMedium="Print"><Volume>69</Volume><Issue>4</Issue><PubDate><MedlineDate>2011 Jul-Aug</MedlineDate></PubDate></JournalIssue><Title>Annales de biologie clinique</Title><ISOAbbreviation>Ann. Biol. Clin. (Paris)</ISOAbbreviation></Journal><ArticleTitle>[Somatostatin in breast cancer].</ArticleTitle><Pagination><MedlinePgn>385-91</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1684/abc.2011.0588</ELocationID><Abstract><AbstractText>In man, somatostatin is a hormone mostly produced by hypothalamus. It plays different parts in hormonal regulation through many specific receptors in human body. It has also two interesting actions such as an anti-secretory activity, mostly on the gastrointestinal system and an antiproliferative action on tumor cells. Many synthetic somatostatin analogues, more stable than the natural one, have been developed and are already used in digestive surgery to treat postoperative digestive fistula. Also, the development of specific polyclonal antibodies allowed the identification of five specific somatostatin receptors and their localization in different cell species. The presence of the five receptors in breast cancer cells has than been demonstrated. The purpose of this literature review is to clarify the potential antitumor effect of somatastatin analogues in breast cancer; its use as a preventive agent on lymphorrhea after breast surgery and its employment in imaging for early breast cancer detection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Frati</LastName><ForeName>Albane</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Service de gynécologie obstétrique, Hôpital Tenon, APHP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antoine</LastName><ForeName>Martine</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Rodenas</LastName><ForeName>Anita</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Gligorov</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Rouzier</LastName><ForeName>Roman</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Chéreau</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>La somatostatine dans le cancer du sein.</VernacularTitle></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Ann Biol Clin (Paris)</MedlineTA><NlmUniqueID>2984690R</NlmUniqueID><ISSNLinking>0003-3898</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018931">Antineoplastic Agents, Hormonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>51110-01-1</RegistryNumber><NameOfSubstance UI="D013004">Somatostatin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018931" MajorTopicYN="N">Antineoplastic Agents, Hormonal</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055088" MajorTopicYN="N">Early Detection of Cancer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008408" MajorTopicYN="N">Mastectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013004" MajorTopicYN="N">Somatostatin</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21896402</ArticleId><ArticleId IdType="pii">abc.2011.0588</ArticleId><ArticleId IdType="doi">10.1684/abc.2011.0588</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002470 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002470 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:21896402
|texte= [Somatostatin in breast cancer].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:21896402" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |